These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 491921)

  • 1. [Thrombocytic function, plasmatic blood coagulation and fibrinolysis in chronic arterial occlusive disease. Study with pentoxifilline].
    Angelkort B
    Med Welt; 1979 Aug; 30(34):1239-43. PubMed ID: 491921
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of pentoxifylline on blood viscosity and peripheral hemodynamics in patients with peripheral occlusive arteriopathies].
    Guerrini M; Pecchi S; Rossi C; Cappelli R; Pieragalli D; Acciavatti A
    Ric Clin Lab; 1981; 11 Suppl 1():265-79. PubMed ID: 7188114
    [No Abstract]   [Full Text] [Related]  

  • 3. [Blood rheology in chronic arterial occlusive disease as influenced by vasodilators (author's transl)].
    Störmer B; Kleinschmidt F; Loose D; Kremer K
    Dtsch Med Wochenschr; 1978 Apr; 103(16):694-8. PubMed ID: 639718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of pentoxifylline on the deformability of erythrocytes and on the muscular oxygen pressure in patients with chronic arterial disease.
    Ehrly AM
    J Med; 1979; 10(5):331-8. PubMed ID: 294470
    [No Abstract]   [Full Text] [Related]  

  • 5. Significance of antithrombotic effect in drug therapy of the chronic arterial occlusive disease.
    Angelkort B
    Ric Clin Lab; 1981; 11 Suppl 1():215-21. PubMed ID: 7188109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemocoagulation, fibrinolytic and rheologic parameters in ischemic vasculopathy. Effects of pentoxifylline in the treatment of acute cerebral vasculopathy].
    Muggeo M; Calabrò A; Businaro V; Patussi L; Volpe A; Signorini GP; Crepaldi G
    Ric Clin Lab; 1981; 11 Suppl 1():353-71. PubMed ID: 7188124
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experience with pentoxifylline in chronic obliterative disease of the leg arteries in hospitalized and ambulatory patients].
    Sondern W; Leube G
    Med Welt; 1979 Sep; 30(37):1367-9. PubMed ID: 502814
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical trial of Trental 100 in patients with peripheral arterial occlusive diseases (author's transl)].
    von Westphalen JG
    MMW Munch Med Wochenschr; 1977 Jul; 119(26):901-4. PubMed ID: 408616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood fluidity and coagulation phenomena in chronic arterial occlusive disease.
    Angelkort B; Boateng K; Maurin N
    J Int Med Res; 1980; 8(3):242-6. PubMed ID: 7389992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic efficacy of pentoxifylline in peripheral artery diseases: its clinical value].
    Benignetti G; Fabbri F; Benvenuti C
    Clin Ter; 1983 Feb; 104(4):297-304. PubMed ID: 6861465
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical pharmacology of vasoactive substances: study on pentoxifylline].
    Pupita F; Rotatori P; Frausini G
    Ric Clin Lab; 1981; 11 Suppl 1():293-302. PubMed ID: 7188116
    [No Abstract]   [Full Text] [Related]  

  • 12. [The treatment of chronic arterial bloodcirculation interference (author's transl)].
    Mund-Hoym WD
    Schweiz Rundsch Med Prax; 1978 Oct; 67(43):1593-9. PubMed ID: 714861
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of chronic occlusive arterial disease with pentoxifylline: changes in clinical and haemodynamic parameters.
    Schweiger H; Ortmeier CJ
    Pharmatherapeutica; 1989; 5(5):298-304. PubMed ID: 2526340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical results of pentoxifylline use in a community peripheral vascular surgical practice.
    Smith MA; Fish RC
    Monogr Atheroscler; 1990; 15():27-9. PubMed ID: 2296248
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies of the clinical pharmacology and therapeutic efficacy of pentoxifylline in peripheral obstructive arterial disease.
    Di Perri T; Carandente O; Vittoria A; Guerrini M; Messa GL
    Angiology; 1984 Jul; 35(7):427-35. PubMed ID: 6540539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease.
    Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
    J Med; 1988; 19(2):89-107. PubMed ID: 3049876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Training by walking and drug therapy of peripheral arterial occlusive disease].
    Kiesewetter H; Blume J; Jung F; Gerhards M; Leipnitz G
    Vasa Suppl; 1987; 20():384-7. PubMed ID: 3321495
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of circulation disorders with pentoxifylline. A double-blind study with Trental].
    Tonak J; Knecht H; Groitl H
    Med Monatsschr; 1977 Oct; 31(10):467-72. PubMed ID: 337089
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of risk factors and coagulation phenomena on the fluidity of blood in chronic arterial occlusive disease.
    Angelkort B; Kiesewetter H
    Scand J Clin Lab Invest Suppl; 1981; 156():185-8. PubMed ID: 6948383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Whole blood viscosity in patients with acral arterial occlusive diseases and their modification by rheologically active drugs].
    Runge E; Thiele P
    Z Gesamte Inn Med; 1987 Mar; 42(5):137-41. PubMed ID: 3590891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.